Irmela Mantel

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


103 publications

Sous presse | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2001 |
Sous presse
 
Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration.
Gigon A., Iskandar A., Kasser S., Naso S., Zola M., Mantel I. Eye. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C39C13503BB]
 
Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand.
Pietzuch M., Mantel I., Ambresin A., Tappeiner C., Nagyova D., Donati G., Pfister I.B., Schild C., Garweg J.G. Journal of ocular pharmacology and therapeutics. Peer-reviewed.
[DOI][Pmid][serval:BIB_B612DB5BAB1F]
2023
High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.
Bousquet E., Chenevier-Gobeaux C., Jaworski T., Torres-Villaros H., Zola M., Mantel I., Kowalczuk L., Matet A., Daruich A., Zhao M. et al., 2023/09. Ophthalmology science, 3 (3) p. 100278. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ACD5958847C7]
 
Indocyanine green angiography of type 1 macular neovascularization in age-related macular degeneration and central serous chorioretinopathy reveals different disease mechanisms.
Zola M., Bousquet E., Favard C., Gigon A., Mantel I., Behar-Cohen F., 2023/08/01. Retina, 43 (8) pp. 1255-1263. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3AAD3D4E3C47]
In Vivo Retinal Pigment Epithelium Imaging using Transscleral Optical Imaging in Healthy Eyes.
Kowalczuk L., Dornier R., Kunzi M., Iskandar A., Misutkova Z., Gryczka A., Navarro A., Jeunet F., Mantel I., Behar-Cohen F. et al., 2023/03. Ophthalmology science, 3 (1) p. 100234. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3AA5ECBEC809]
2022
 
Type one macular neovascularization in central serous chorioretinopathy: Short-term response to anti-vascular endothelial growth factor therapy.
Lejoyeux R., Behar-Cohen F., Mantel I., Ruiz-Medrano J., Mrejen S., Tadayoni R., Gaudric A., Bousquet E., 2022/10. Eye, 36 (10) pp. 1945-1950. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3059AB03BF52]
Automated foveal location detection on spectral-domain optical coherence tomography in geographic atrophy patients.
Montesel A., Gigon A., Mosinska A., Apostolopoulos S., Ciller C., De Zanet S., Mantel I., 2022/07. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 260 (7) pp. 2261-2270. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C22609D230E]
 
Human retinal pigment epithelium cells can be imaged in vivo with a novel adaptive optics camera using transscleral illumination
Simon-Zoula Sonja, Kowalczuk Laura, dornier R, Kunzi Mathieu, Iskandar Antonio, Misutkova Zuzana, Gryczka Aurélia, Navarro Aurélie, Jeunet Fanny, Mantel Irmela et al., 2022/06/01. p. 1056 dans Investigative Ophthalmology & Visual Science . Peer-reviewed.
[serval:BIB_334E7414581A]
 
Late hyperfluorescent plaque in type 1 choroidal neovascularization in age-related macular degeneration and central serous chorioretinopathy
Zola Marta, Bousquet Elodie, Favard Catherine, Gigon Anthony, Mantel Irmela, Behar-Cohen Francine F, 2022/06/01. p. 2667 dans Investigative Ophthalmology & Visual Science. Peer-reviewed.
[serval:BIB_5CE6D7372ECA]
 
SOIN - MI Data Lab: Personalized Ophthalmology Through Collaborative Data Collection and Dynamic Patient Consent.
Bergin C., Mantel I., Schlingemann R.O., Tomasoni M., Wolfensberger T.J., 2022/05/25. Studies in health technology and informatics, 294 pp. 281-282. Peer-reviewed.
[DOI][Pmid][serval:BIB_B7196B40952E]
TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration.
Montesel A., Gigon A., Giacuzzo C., Mantel I., Eandi C.M., 2022/04/01. Retina, 42 (4) pp. 634-642. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_950CBC9C6DF9]
 
Validation of central serous chorioretinopathy multimodal imaging-based classification system.
Chhablani J., Behar-Cohen F., Central Serous Chorioretinopathy International Group, 2022/04. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 260 (4) pp. 1161-1169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1CCB2FAB3D53]
Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men.
Bousquet E., Torres-Villaros H., Provost J., Elalouf M., Gigon A., Mantel I., Timsit A., Behar-Cohen F., 2022/03/19. Journal of clinical medicine, 11 (6) p. 1706. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_654D52A25C9C]
Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study.
Gigon A., Iskandar A., Eandi C.M., Mantel I., 2022/03/08. International journal of retina and vitreous, 8 (1) p. 19. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3D232EB3A481]
Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors.
Moret E., Ambresin A., Gianniou C., Bijon J., Besse-Hayat C., Bogiatzi S., Hohl D., Spertini F., Mantel I., 2022/03. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 260 (3) pp. 1005-1014. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C16845CB364E]
2021
Fully-automated atrophy segmentation in dry age-related macular degeneration in optical coherence tomography.
Derradji Y., Mosinska A., Apostolopoulos S., Ciller C., De Zanet S., Mantel I., 2021/11/08. Scientific reports, 11 (1) p. 21893. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4CA55724AC15]
Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration.
Gigon A., Mosinska A., Montesel A., Derradji Y., Apostolopoulos S., Ciller C., De Zanet S., Mantel I., 2021/11/01. Translational vision science & technology, 10 (13) p. 18. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58D22BF25735]
Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment.
Zola M., D'Alessandro E., Sherif M., Nguyen A., De Azevedo D., Haeller C., Forestier E., Mantel I., 2021/06. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 259 (6) pp. 1477-1486. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B0D6846D3B3]
Automated Quantification of Pathological Fluids in Neovascular Age-Related Macular Degeneration, and Its Repeatability Using Deep Learning.
Mantel I., Mosinska A., Bergin C., Polito M.S., Guidotti J., Apostolopoulos S., Ciller C., De Zanet S., 2021/04/01. Translational vision science & technology, 10 (4) p. 17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E7CF1BEDCCB0]
2020
Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration.
Marquis L.M., Mantel I., 2020/08. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 258 (8) pp. 1591-1596. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8C74639C8080]
 
Reply.
Mantel I., 2020/08. Retina, 40 (8) pp. e41-e42. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE277A176D56]
 
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
Romdhane K., Zola M., Matet A., Daruich A., Elalouf M., Behar-Cohen F., Mantel I., 2020/07. The British journal of ophthalmology, 104 (7) pp. 910-916. Peer-reviewed.
[DOI][Pmid][serval:BIB_CC5CE8E7913A]
 
Atypische Retro-ILM-Blutung bei homozygoter Sichelzellerkrankung [Atypical Retro Internal Limiting Membrane Haemorrhage in Homozygous Sickle Cell Disease]
Voide N., Mantel I., Ambresin A., 2020/04. Klinische Monatsblatter fur Augenheilkunde, 237 (4) pp. 477-479. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C028D8F3AC3B]
Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment.
Mantel I., Borgo A., Guidotti J., Forestier E., Kirsch O., Derradji Y., Waridel P., Burdet F., Mehl F., Schweizer C. et al., 2020. Frontiers in pharmacology, 11 p. 594087. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_548B1E9F5D9F]
 
MULTIPLE SEROUS PIGMENT EPITHELIAL DETACHMENTS IN ASSOCIATION WITH MAJOR WEIGHT LOSS: CASE REPORT AND REVIEW OF THE LITERATURE.
Kheir V., Ambresin A., Mantel I., 2020. Retinal cases & brief reports, 14 (1) pp. 72-76. Peer-reviewed.
[DOI][Pmid][serval:BIB_EC42FE9178BD]
2019
 
Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy
Zola Marta, Daruich Alejandra, Matet Alexandre, Mantel Irmela, Behar-Cohen Francine, 2019/08. British Journal of Ophthalmology, 103 (8) pp. 1184-1189. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_31401C83AC20]
 
Factors influencing macular atrophy growth rates in neovascular age-related macular degeneration treated with ranibizumab or aflibercept according to an observe-and-plan regimen.
Mantel I., Zola M., De Massougnes S., Dirani A., Bergin C., 2019/07. The British journal of ophthalmology, 103 (7) pp. 900-905. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA0EEF0A2555]
Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration.
Mantel I., Zola M., Mir O., Gaillard R., Behar-Cohen F., 2019/06. The British journal of ophthalmology, 103 (6) pp. 811-815. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A0255087CC94]
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen.
Mantel I., Dirani A., Zola M., Parvin P., De Massougnes S., Bergin C., 2019/05. Retina, 39 (5) pp. 906-917. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_160E4E5271F0]
 
Zentrale seröse Chorioretinopathie mit choroidaler Neovaskularisation: die Entdeckungsrate bei multimodaler Bildgebung [Choroidal Neovascularisation Complicating Chronic Central Serous Chorioretinopathy: The Discovery Rate on Multimodal Imaging]
Romdhane K., Mantel I., 2019/04. Klinische Monatsblatter fur Augenheilkunde, 236 (4) pp. 536-541. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CA18FCAB8C86]
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.
Zhao M., Mantel I., Gelize E., Li X., Xie X., Arboleda A., Seminel M., Levy-Boukris R., Dernigoghossian M., Prunotto A. et al., 2019/01/21. Nature communications, 10 (1) p. 369. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C7716BDC7511]
2018
 
Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor.
Nguyen NCI, Fabro F., Ambresin A., Ezziat S., Bergin C., Mazzocato C., Mantel I., 2018/09. Eye, 32 (9) pp. 1544-1546. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AF97AEC37485]
 
GOOD VISUAL OUTCOME AT 1 YEAR IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH PIGMENT EPITHELIUM DETACHMENT: Factors Influencing the Treatment Response.
de Massougnes S., Dirani A., Mantel I., 2018/04. Retina, 38 (4) pp. 717-724. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F36B42AA95E7]
 
Atypical retro internal limiting membrane hemorrhage in homozygous sickle­ cell disease: a case report.
Ambresin Aude, Voide Nathalie, Mantel Irmela, 2018. dans EPOS.
[serval:BIB_FCFFB53562DA]
 
Natural history of PAMM
zola Marta, Ambresin Aude, Mantel Irmela, Borruat Francois Xavier, 2018. dans SOG.
[serval:BIB_D2F9C1D70242]
Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance.
Dirani A., Mantel I., 2018. Clinical ophthalmology, 12 pp. 593-600. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D44123348824]
 
Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration.
Mantel I., Gillies M.C., Souied E.H., 2018. Survey of ophthalmology, 63 (5) pp. 638-645. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B1DF7CEB9047]
2017
EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.
Kowalczuk L., Matet A., Dirani A., Daruich A., Ambresin A., Mantel I., Spaide R.F., Turck N., Behar-Cohen F., 2017/12. Retina, 37 (12) pp. 2226-2237. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7E8EB5F88A93]
Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept.
Parvin P., Zola M., Dirani A., Ambresin A., Mantel I., 2017/11. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 255 (11) pp. 2127-2134. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4D5A56233621]
ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.
Daruich A., Matet A., Marchionno L., De Azevedo J.D., Ambresin A., Mantel I., Behar-Cohen F., 2017/10. Retina, 37 (10) pp. 1905-1915. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FDE7EDB0DCC6]
2016
 
Dégénérescence maculaire lié à l'âge
Ambresin Aude, Mantel Irmela, 2016/09/06. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (36).
[DOI][serval:BIB_A97E60F97636]
 
PIGMENT EPITHELIAL DETACHMENT RESPONSE TO AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO RANIBIZUMAB: Time Course and Drug Effects.
de Massougnes S., Dirani A., Ambresin A., Decugis D., Marchionno L., Mantel I., 2016/05. Retina (philadelphia, Pa.), 36 (5) pp. 881-888. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DB023541219B]
 
Behandlung von submakulärer Blutung mittels Vitrektomie, Gastamponade und Anti-VEGF-Injektionen [Vitrectomy with Gas Tamponade and anti-VEGF Injections for the Management of Submacular Hemorrhage]
Sadeghi Y., Elalouf M., Mantel I., Pournaras J.A., 2016/04. Klinische Monatsblatter fur Augenheilkunde, 233 (4) pp. 500-502. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3DF1C370CE91]
 
CONVERSION TO AFLIBERCEPT THERAPY VERSUS CONTINUING WITH RANIBIZUMAB THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEPENDENT ON MONTHLY RANIBIZUMAB TREATMENT.
Mantel I., Gianniou C., Dirani A., 2016. Retina, 36 (1) pp. 53-58. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FC6ED113CE21]
2015
 
Œil et cancer [The eye and cancer]
Schalenbourg A., Mantel I., 2015/12/16. Revue medicale suisse, 11 (499) pp. 2395-2398. Peer-reviewed.
[Pmid][serval:BIB_B715D5A01222]
 
Factors Influencing the Treatment Response of Pigment Epithelium Detachment in Age-Related Macular Degeneration.
Dirani A., Ambresin A., Marchionno L., Decugis D., Mantel I., 2015. American Journal of Ophthalmology, 160 (4) pp. 732-738.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1E3740E41A0F]
 
Incidence of outer retinal tubulation in ranibizumab-treated age-related macular degeneration.
Dirani A., Gianniou C., Marchionno L., Decugis D., Mantel I., 2015. Retina, 35 (6) pp. 1166-1172. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_58FEEA863E53]
Optimizing the Anti-VEGF Treatment Strategy for Neovascular Age-Related Macular Degeneration: From Clinical Trials to Real-Life Requirements.
Mantel I., 2015. Translational Vision Science and Technology, 4 (3) p. 6. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EEE3487D8E6C]
 
Recurrent Macular Edema in Central Retinal Vein Occlusion Treated with Intravitreal Ranibizumab using a Modified Treat and Extend Regimen.
Dirani A., Mantel I., Ambresin A., 2015. Klinische Monatsblatter Fur Augenheilkunde, 232 (4) pp. 538-541. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8346B3551C84]
 
Refractory intraretinal or subretinal fluid in neovascular age-related macular degeneration treated with intravitreal ranizubimab: Functional and Structural Outcome.
Gianniou C., Dirani A., Jang L., Mantel I., 2015. Retina, 35 (6) pp. 1195-1201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7EB9943072D0]
 
Refractory subretinal fluid in patients with neovascular age-related macular degeneration treated with intravitreal ranibizumab: visual acuity outcome.
Jang L., Gianniou C., Ambresin A., Mantel I., 2015. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie, 253 (8) pp. 1211-1216. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_96A514CCF84A]
 
The Effect of Switching Ranibizumab to Aflibercept in Refractory Cases of Macular Edema Secondary to Ischemic Central Vein Occlusion.
Lehmann-Clarke L., Dirani A., Mantel I., Ambresin A., 2015. Klinische Monatsblatter Fur Augenheilkunde, 232 (4) pp. 552-555. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F865076E6CD]
 
Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results.
Gianniou C., Dirani A., Ferrini W., Marchionno L., Decugis D., Deli A., Ambresin A., Mantel I., 2015. Eye (london, England), 29 (3) pp. 342-349.
[DOI][WoS][Pmid][serval:BIB_0FECC5CD4C9A]
2014
 
Complement Factor B Polymorphism and the Phenotype of Early Age-related Macular Degeneration.
Mantel I., Ambresin A., Moetteli L., Droz I., Roduit R., Munier F.L., Schorderet D.F., 2014. Ophthalmic Genetics, 35 (1) pp. 12-17. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_51AA14B02CD8]
 
Evanescent vaso-occlusive choroidal pseudo-tumor with acute painful onset: a presumed vortex vein occlusion.
Mantel I., Schalenbourg A., Zografos L., 2014. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie, 252 (5) pp. 753-759. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9B7AE39F95D1]
 
Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study.
Casparis H., Wolfensberger T.J., Becker M., Eich G., Graf N., Ambresin A., Mantel I., Michels S., 2014. Retina (philadelphia, Pa.), 34 (1) pp. 12-17. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_330CBF0B7150]
 
Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.
Mantel I., Schalenbourg A., Bergin C., Petrovic A., Weber D.C., Zografos L., 2014. American Journal of Ophthalmology, 158 (4) pp. 693-701.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8D8578A22825]
Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen.
Mantel I., Niderprim S.A., Gianniou C., Deli A., Ambresin A., 2014. British Journal of Ophthalmology, 98 (9) pp. 1192-1196. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6DDD88E26EF8]
Resolution of foveal detachment in dome-shaped macula after treatment by spironolactone: report of two cases and mini-review of the literature.
Dirani A., Matet A., Beydoun T., Mantel I., Behar-Cohen F., 2014. Clinical Ophthalmology (auckland, N.z.), 8 pp. 999-1002. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_222D6FB3F953]
2013
Comparison of fundus autofluorescence images acquired by the confocal scanning laser ophthalmoscope (488 nm excitation) and the modified Topcon fundus camera (580 nm excitation).
Deli A., Moetteli L., Ambresin A., Mantel I., 2013. International Ophthalmology, 33 (6) pp. 635-643. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C208BF42172]
Prospective study evaluating the predictability of need for retreatment with intravitreal ranibizumab for age-related macular degeneration.
Mantel I., Deli A., Iglesias K., Ambresin A., 2013. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie, 251 (3) pp. 697-704.
[URN][DOI][WoS][Pmid][serval:BIB_86D413480367]
2012
 
Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications.
Mantel I., Schalenbourg A., Zografos L., 2012. American Journal of Ophthalmology, 153 (5) pp. 910-922.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FBDD89639F97]
2011
Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration.
Mariani A., Deli A., Ambresin A., Mantel I., 2011. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, 249 (11) pp. 1635-42. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_431C65CC7872]
 
Comparison of central macular thickness (CMT) measurement between time domain and spectral domain (SD) optical coherence tomography (OCT) and reproducibility of SD OCT in active neovascular AMD
Ambresin A., Mantel I., Deli A., 2011., SOE/AAO pp. FP-RET-067 dans Joint Congress of SOE/AAO 2011, European Society of Ophthalmology/American Academy of Ophthalmology, 4-7 June, Geneva.
[serval:BIB_F8F3ECFB70D6]
 
Comparison of fundus autofluorescence between fundus camera (Topcon) and confocal scanning laser ophthalmoscope (HRA) in various pathologies
Mantel I., Ambresin A., Deli A., 2011., SOE/AAO pp. FP-RET-068 dans Joint Congress of SOE/AAO, European Society of Ophthalmology/American Academy of Ophthalmology, 4-7 June, Geneva.
[serval:BIB_8F3F0B6C9A7D]
 
Intravitreal ranibizumab for age-related macular degeneration - optical coherence tomography guided retreatment intervals and their intra- and inter-individual variability
Mantel I., 2011., European Society of Retina Specialists dans 11th Euretina Congress, London 26-29 May.
[serval:BIB_A4E9A8EC6902]
 
Intravitreal ranibizumab for age-related macular degeneration : optical coherence tomography guided retreatment intervals and their intra- and inter-individual variability
Deli A., Ambresin A., Mantel I., 2011., SOE/AAO pp. FP-RET-064 dans Joint Congress of SOE/AAO, European Society of Ophthalmology/American Academy of Ophthalmology, 4-7 June, Geneva.
[serval:BIB_77964B2209F1]
 
Intravitreal ranibizumab for AMD : the individual rhythm of OCT guided retreatment intervals
Mantel I., Ambresin A., Deli A., 2011., German Society of Ophthalmology pp. Abstract 64P dans V. International Symposium of the German Ophthalmological Society (DOG), Baden-Baden September 8-10.
[serval:BIB_DADF575D1E1C]
 
Intravitreal Ranibizumab in the Treatment of Predominantly Hemorrhagic Lesions in Exudative Age-Related Macular Degeneration.
Konstantinidis L., Mantel I., Zografos L., Ambresin A., 2011. Klinische Monatsblatter Fur Augenheilkunde, 228 (4) pp. 288-292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19C80A4FB918]
 
Pronostic visual des occlusions vasculaires veineuses (OVR) traitées par anti-VEGF intravitréens
Ambresin A., Mantel I., 2011., Société Suisse d'Ophtalmologie pp. S56 dans Ophta.
[serval:BIB_1F42E377732D]
 
Ranibizumab intravitréen pour DMLA : le rythme individuel du besoin de retraitement basé sur l'OCT
Mantel I., Ambresin A., Deli A., 2011., Société Suisse d'Ophtalmologie pp. S56 dans Ophta.
[serval:BIB_AD5783EACAB0]
2010
 
Intravitreal ranibizumab injection for the treatment of large submacular hemorrhage Due to neovascular age-related macular degeneration
Konstantinidis Lazaros, 2010/09/19., 103e Congrès annuel de la Société Suisse d’Ophtalmologie pp. S68 dans Ophta 2010.
[serval:BIB_A1F43AAC31E8]
 
Comparison of Fundus Autofluorescence Between Fundus Camera (Topcon) and Confocal Scanning Laser Ophthalmoscope (HRA) in Various Pathologies
Deli A., Ambresin A., Mantel I., 2010., ARVO E-Abstract 4369/A202 dans Investigative Ophthalmology and Visual Science. Peer-reviewed.
[serval:BIB_E7F41B2BF00A]
 
Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.
Konstantinidis L., Mantel I., Zografos L., Ambresin A., 2010. European Journal of Ophthalmology, 20 (5) pp. 955-958. Peer-reviewed.
[WoS][Pmid][serval:BIB_B4F448B6667D]
 
Le traitement de la DMLA exsudative à prédominance hémorragique par injections intravitréennes de ranibizumab
Konstantinidis L., Mantel I., Zografos L., Ambresin A., 2010., Société Suisse d'Ophtalmologie pp. S68 dans Ophta.
[serval:BIB_ABF28BA1E709]
 
Ophtalmologie. Thérapies anti-vasoprolifératives
Ambresin A., Zografos L., Mantel I., 2010. Revue Médicale Suisse, 6 (231) pp. 51-54.
[Pmid][serval:BIB_FE609AF9447C]
Optimal treatment of retinal angiomatous proliferation.
Konstantinidis Lazaros, Zografos Leonidas, Mantel Irmela, Ambresin Aude, 2010. Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie, 248 (2) p. 289. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A898CB884A43]
 
Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study [reply]
Mantel I., Zografos L., 2010. American Journal of Ophthalmology, 149 (6) p. 1014. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C77995F1DA4A]
 
Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration.
Konstantinidis L., Ambresin A., Zografos L., Mantel I., 2010. Acta Ophthalmologica, 88 (7) pp. 736-741. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_00DF6E6969CB]
2009
 
Analyse rétrospective de l'efficacité de l'injection de ranibizumab dans la choriorétinopathie séreuse centrale chronique (CSRC)
Ambresin A., Mantel I., 2009., Société Suisse d'Ophtalmologie pp. S75 dans Ophta.
[serval:BIB_9F3A144DA236]
 
Evaluation de ranibizumab pour la DMLA exsudative dans la pratique clinique : les facteurs importants dans le suivi individualisé
Mantel I., Mariani A., Ambresin A., 2009., Société Suisse d'Ophtalmologie pp. S56 dans Ophta.
[serval:BIB_BCD70F9F9373]
Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization.
Konstantinidis L., Mantel I., Pournaras J.A., Zografos L., Ambresin A., 2009. Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 247 (3) pp. 311-318. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7FF3875D6472]
Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).
Konstantinidis L., Mameletzi E., Mantel I., Pournaras J.A., Zografos L., Ambresin A., 2009. Graefe's Archive for Clinical and Experimental Ophthalmology, 247 (9) pp. 1165-1171. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7BC299FDB2D0]
Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia.
Konstantinidis L., Mantel I., Zografos L., Ambresin A., 2009. Graefe's Archive for Clinical and Experimental Ophthalmology [Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie], 247 (11) pp. 1567-1569.
[URN][DOI][WoS][Pmid][serval:BIB_E7DF53097786]
 
Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study.
Mantel Irmela, Uffer Sylvie, Zografos Leonidas, 2009. American Journal of Ophthalmology, 148 (6) pp. 932-938. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_170F47FE47A2]
2008
 
Intravitreal Ranibizumab for the treatment of pigment epithelium detachement associated with an occult choroidal neovascularization secondary to age related macular degeneration
Konstantinidis Lazaros, 2008/06/05., Actes du 41ème Congrès panhellénique d’ophtalmologie dans Actes du 41ème Congrès panhellénique d’ophtalmologie,.
[serval:BIB_2B01E5C4DA5B]
 
Intravitreal Ranibizumab in the treatment of retinal angiomatous proliferation
Konstantinidis Lazaros, 2008/05/06. dans Actes du 41ème Congrès panhellénique d’ophtalmologie.
[serval:BIB_A4B3B6815646]
 
Early clinical experience with ranibizumab for occult and minimally classic neovascular membranes in age-related macular degeneration.
Mantel I., Zografos L., Ambresin A., 2008. Ophthalmologica, 222 (5) pp. 321-323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_362E24BE75B4]
 
Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism.
Droz I., Mantel I., Ambresin A., Faouzi M., Schorderet D.F., Munier F.L., 2008. British Journal of Ophthalmology, 92 (4) pp. 513-517. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BF4F2808F5B2]
 
Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology.
Mantel I., Ramchand K.V., Holder G.E., Ohbayashi M., Morohoshi K., Patel N., Toda M., Fitzke F.W., Bird A.C., Ono S.J., 2008. Experimental and molecular pathology, 84 (2) pp. 90-101. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BAED2A34462D]
 
Prise en charge de la dégénérescence maculaire liée à l'âge : de véritables révolutions thérapeutiques
Ambresin A., Mantel I., 2008. Tribune Médicale 14 pp. 18, 20-21.
[serval:BIB_60794A40E325]
 
Retinale Pigmentepithelrisse nach Behandlung von klassischen Neovaskularisationsmembranen bei AMD mit intravitrealem Ranibizumab
Konstantinidis L., Ambresin A., Zografos L., Mantel I., 2008., Société Suisse d'Ophtalmologie pp. S107 dans Ophta.
[serval:BIB_7D04BD6D390A]
2007
 
Interferon-associated retinopathy: a case report.
Mantel I., Konstantinidis L., Zografos L., 2007/04. Klinische Monatsblätter für Augenheilkunde, 224 (4) pp. 350-352. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D99F63586963]
 
La stratégie thérapeutique anti-VEGF améliore le pronostic visuel de la dégénérescence maculaire liée à l'âge exsudative [Intravitreal anti-VEGF injections improve the visual prognosis of wet age related macular degeneration].
Ambresin A., Mantel I., 2007. Revue Médicale Suisse, 3 (94) pp. 137-141.
[Pmid][serval:BIB_A800D8F61C38]
2006
 
La Dégénérescence Maculaire Liée à l'Age
Mantel I, 2006/12. Gériatrie pratique pp. 23-26. Peer-reviewed.
[serval:BIB_7B8341EF3E9F]
 
Interferon Retinopathy’
Mantel I., Konstantinidis Lazaros, 2006/05/06., Congrès SSO 2006 dans Ophta 2006.
[serval:BIB_D3CF55E1F375]
 
A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease.
Abu-Safieh L., Vithana E.N., Mantel I., Holder G.E., Pelosini L., Bird A.C., Bhattacharya S.S., 2006. Molecular Vision, 12 pp. 384-388. Peer-reviewed.
[Pmid][serval:BIB_667F7FA32B65]
 
Retinal angiomatous proliferation treated with a combination of intravitreal triamcinolone acetonide and photodynamic therapy with verteporfin.
Mantel I., Ambresin A., Zografos L., 2006. European Journal of Ophthalmology, 16 (5) pp. 705-710. Peer-reviewed.
[WoS][Pmid][serval:BIB_D142524133D5]
2005
 
Tomographie a coherence optique dans la Malattia leventinese [Optical coherence tomography in Malattia Leventinese].
Gaillard M.C., Wolfensberger T.J., Uffer S., Mantel I., Pournaras J.A., Schorderet D.F., Munier F.L., 2005/03. Klinische Monatsblätter für Augenheilkunde, 222 (3) pp. 180-185.
[DOI][WoS][Pmid][serval:BIB_3836D25E95D6]
2004
 
Subretinal choroidal neovascularization associated with choroidal nevus.
Zografos L., Mantel I., Schalenbourg A., 2004/04. European Journal of Ophthalmology, 14 (2) pp. 123-131. Peer-reviewed.
[WoS][Pmid][serval:BIB_3791DB0D3D7B]
 
Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
Mantel I., Brantley M.A., Bellmann C., Robson A.G., Holder G.E., Taylor A., Anderson G., Moore A.T., 2004. Klinische Monatsblätter für Augenheilkunde, 221 (5) pp. 427-430.
[DOI][WoS][Pmid][serval:BIB_33330]
2003
 
Photocoagulation des vaisseaux retiniens nourriciers d'une anastomose chorioretinienne dans le cadre d'une degenerescence maculaire liee a l'age. [Photocoagulation of the retinal feeder vessels of a chorioretinal anastomosis in age-related macular degeneration]
Mantel I., Zografos L., 2003/05. Journal Français d'Ophtalmologie, 26 (5) pp. 493-7.
[WoS][Pmid][serval:BIB_87F6DDF7011E]
2001
 
A simple treatment for chronic postoperative hypotony of unknown etiology: the injection of balanced salt solution into the anterior chamber.
Mantel I., Schipper I., 2001. Ophthalmic surgery and lasers, 32 (3) pp. 250-254. Peer-reviewed.
[WoS][Pmid][serval:BIB_20816]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University